Showing results (151-160 of 229) with videos related to
Sort By:
Pageof 23
Journal of Neurosurgery|July 31, 2012
Early induction of hypothermia for evacuated intracranial hematomas: a post hoc analysis of two clinical trialsGuy L Clifton, Christopher S Coffey, Sierra Fourwinds, et al.Parkinsonism & Related Disorders|October 17, 2021
Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's diseaseAlberto J Espay, David-Erick Lafontant, Kathleen L Poston, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 26, 2021
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosisRobert J Fox, Paola Raska, Christian Barro, et al.Stroke|April 5, 2014
Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experienceSharon D Yeatts, Renee H Martin, Christopher S Coffey, et al.Neurology|December 3, 2020
Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS StudyRobert T Naismith, Robert A Bermel, Christopher S Coffey, et al.Journal of Parkinson'S Disease|August 28, 2019
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change MeasuresLana M Chahine, Andrew Siderowf, Janel Barnes, et al.Journal of the American College of Clinical Pharmacy : JACCP|June 2, 2023
A cluster randomized trial to evaluate a centralized remote clinical pharmacy service in large, health system primary care clinicsKorey Kennelty, Christopher S Coffey, Gail Ardery, et al.Annals of Clinical and Translational Neurology|January 18, 2021
Response to ibudilast treatment according to progressive multiple sclerosis disease phenotypeAndrew D Goodman, Janel K Fedler, Jon Yankey, et al.Circulation|June 30, 2010
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, et al.Plos One|August 14, 2009
Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methodsMai A Elobeid, Miguel A Padilla, Theresa McVie, et al.Pageof 23